iwi Raises $10M in First Close of New Funding Round

Qualitas Health, DBA iwi, Houston, Texas, plant-based omega-3 company, secured $10m in venture funding at a $73 million post-money valuation.

The round was led by foodTech investor PeakBridge VC, Malta, together with Arancia Group, a privately owned Mexico-based food ingredient/food service conglomerate, Minrav (the company’s largest investor) and additional private investors. Additional convertible notes held by Minrav Holdings, Sasa, Trucent and other single investors are converted to equity.

The investment will accelerate customer acquisition, and commercialization of the company’s unique plant-based protein. The funds will also be used to deepen its clinical science and IP and accelerate its expansion into additional geographies.

Founded by Erich Sieber and Nadav Berger and led by Miguel Calatayud, CEO, Qualitas Health, iwi is a producer of the highest absorption polar lipid EPA omega-3 marketed direct-to-consumer and to retailers in the US market. The company currently produces proprietary, clinically proven, high-absorption omega-3. It markets 15 supplement SKUs under the iwi brand in the US, including soft gels and functional gummies. iwi has built a strong direct-to-consumer platform (DTC), and has an additional presence in more than 5,000 US retailer outlets.



Join the discussion